Home » Newsletters » BioWorld Science

BioWorld Science

June 17, 2013

View Archived Issues

Urinary exosomal microRNA downregulated in chronic kidney disease

Novel, non-chemical, approach towards regenerative medical therapy

18F-PS-TumorVue for dual-modality PET/NIRF imaging

Japanese researchers divulge new dimer peptides for diabetes

Emory University and Children's Health Care patent novel fusion proteins

Amarantus BioScience and BD Biosciences to work on test for Alzheimer's disease

Apceth receives approval to conduct stem cell trial in cancer

Bioprojet-Biotech presents novel chemically modified H3 receptor ligands

NICE issues positive appraisal recommendation for Iluvien

Bristol-Myers Squibb and Simcere to develop and commercialize Orencia in China

FDA accepts TherapeuticsMD IND for TX12-004HR

Phase I/II clinical studies of ublituximab presented at the EHA conference

CRT, University of Manchester and AstraZeneca to develop new cancer drugs

Knopp Neurosciences to donate phase III data to ALS database

Chinese team patents novel BMP-2 inhibitors

NGM Biopharmaceuticals and MedImmune partner to develop therapies for diabetes and obesity

Celgene presents analyzed results from the NIMBUS phase III trial

CoMentis and Anvyl sign agreement to form Alpharmagen

European approval for Revlimid in MDS

The U.S. Secretary of the Navy divulges new vaccines for bacterial infections

Prograf approved in Japan in new indication

Maintate approved in Japan for atrial fibrillation

Japanese approval of Precedex in non-intubated patients granted

FDA agrees with proposed trial design for Methylene Blue MMX

Humira prefilled syringe approved in Japan for ulcerative colitis

Chugai obtains new approvals in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....